GlassScriptPhysician profile
Abraham K Poulose
NPI 1497753560
$1,117.86
in general payments reported to CMS, 2019-2025
15 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.65 · 2020: $21.59 · 2021: $60.32 · 2022: $181 · 2023: $163 · 2024: $367 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681 · Entertainment: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.52 |
| Entertainment | $141.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $304.75 | 2022-2025 | Clareon |
| Bausch & Lomb Americas INC. | $204.22 | 2024-2025 | Stellaris, Envista Envy Iol, Stellaris |
| Genentech USA, INC. | $187.03 | 2020-2023 | Vabysmo |
| Optos, INC. | $141.47 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Horizon Therapeutics Plc | $60.32 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $40.31 | 2024 | Iolmaster 700 |
| Novartis Pharmaceuticals Corporation | $31.82 | 2019 | |
| Abbvie INC. | $26.54 | 2025 | |
| Coherus Oncology, INC. | $24.35 | 2023 | |
| Biogen, INC. | $22.18 | 2024 | Byooviz |
| Astellas Pharma US INC | $20.46 | 2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $20.08 | 2025 | Eylea |
| Ani Pharmaceuticals, INC. | $18.60 | 2025 | Yutiq |
| Coopervision INC. | $14.90 | 2022 | |
| Travere Therapeutics, INC. | $0.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Poulose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.